Human VCAM-1/CD106 Recombinant Protein (GST tag)
- SKU:
- RPES5448
Description
| Product Name: | Human VCAM-1/CD106 Recombinant Protein (GST tag) |
| Product Code: | RPES5448 |
| Size: | 20µg |
| Species: | Human |
| Expression Host: | E.coli |
| Synonyms: | Vascular Cell Adhesion Protein 1, V-CAM 1, VCAM-1, INCAM-100, CD106, VCAM1, L1CAM |
| Mol Mass: | 47.99 kDa |
| AP Mol Mass: | 45 kDa |
| Tag: | N-GST |
| Purity: | > 95 % as determined by reducing SDS-PAGE. |
| Endotoxin Level: | Please contact us for more information. |
| Bio Activity: | Testing in progress |
| Sequence: | Gln 109-Ser 318 |
| Accession: | P19320 |
| Storage: | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
| Shipping: | This product is provided as lyophilized powder which is shipped with ice packs. |
| Formulation: | Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
| Reconstitution: | Please refer to the printed manual for detailed information. |
| Background: | Vascular cell adhesion molecule 1 (VCAM-1), also known as CD106, is a cell surface sialoglycoprotein belonging to the immunoglobulin superfamily. Two forms of VCAM-1 with either six or seven extracellular Ig-like domains are generated by alternative splicing, with the longer form predominant. VCAM-1 is an endothelial ligand for very late antigen-4 (VLA-4) and α4ß7 integrin expressed on leukocytes, and thus mediates leukocyte-endothelial cell adhesion and signal transduction. VCAM-1 expression is induced on endothelial cells during inflammatory bowel disease, atherosclerosis, allograft rejection, infection, and asthmatic responses. During these responses, VCAM-1 forms a scaffold for leukocyte migration. VCAM-1 also activates signals within endothelial cells resulting in the opening of an "endothelial cell gate" through which leukocytes migrate. VCAM-1 has been identified as a potential anti-inflammatory therapeutic target, the hypothesis being that reduced expression of VCAM-1 will slow the development of atherosclerosis. In addition, VCAM-1-activated signals in endothelial cells are regulated by cytokines indicating that it is important to consider both endothelial cell adhesion molecule expression and function during inflammatory processes. |
Related Products
Human VCAM-1/CD106 Recombinant Protein (His tag)
OverviewProduct Name:Human VCAM-1/CD106 Recombinant Protein (His tag)Product Code:RPES6043Size:20µgSpecies:Human
Human MCP-1 Recombinant Protein (GST tag)
OverviewProduct Name:Human MCP-1 Recombinant Protein (GST tag)Product Code:RPES5456Size:20µgSpecies:HumanExpres
Human KIM-1 Recombinant Protein (GST tag)
OverviewProduct Name:Human KIM-1 Recombinant Protein (GST tag)Product Code:RPES5450Size:20µgSpecies:HumanExpres
Human ATXN2 Recombinant Protein (GST tag)
OverviewProduct Name:Human ATXN2 Recombinant Protein (GST tag)Product Code:RPES5390Size:20µgSpecies:HumanExpres
Human AMPK1 Recombinant Protein (GST tag)
OverviewProduct Name:Human AMPK1 Recombinant Protein (GST tag)Product Code:RPES5401Size:20µgSpecies:HumanExpres